Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Clinical trial NCT03007329 · COMPLETED
Trial details
- NCT number
- NCT03007329
- Sponsor
- Medical University of Vienna
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-08
- Primary completion
- 2019-11-26
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.